C07D 239/10
Oxygen or sulfur atoms
C07D239/10 (Oxygen or sulfur atoms) appears on 239 US grants and 156 published applications in this corpus.
Search patents in C07D- Granted patents
- 239
- Published applications
- 156
- Assignees
- 145
- Inventors
- 797
- Latest grant
- 18 Nov 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 3 | 0 |
| 1977 | 4 | 0 |
| 1978 | 2 | 0 |
| 1979 | 3 | 0 |
| 1980 | 0 | 0 |
| 1981 | 1 | 0 |
| 1982 | 2 | 0 |
| 1983 | 2 | 0 |
| 1984 | 0 | 0 |
| 1985 | 3 | 0 |
| 1986 | 4 | 0 |
| 1987 | 2 | 0 |
| 1988 | 5 | 0 |
| 1989 | 7 | 0 |
| 1990 | 5 | 0 |
| 1991 | 4 | 0 |
| 1992 | 2 | 0 |
| 1993 | 4 | 0 |
| 1994 | 3 | 0 |
| 1995 | 9 | 0 |
| 1996 | 5 | 0 |
| 1997 | 12 | 0 |
| 1998 | 11 | 0 |
| 1999 | 9 | 0 |
| 2000 | 4 | 0 |
| 2001 | 7 | 3 |
| 2002 | 13 | 11 |
| 2003 | 11 | 12 |
| 2004 | 6 | 11 |
| 2005 | 6 | 12 |
| 2006 | 7 | 6 |
| 2007 | 3 | 5 |
| 2008 | 7 | 3 |
| 2009 | 2 | 4 |
| 2010 | 5 | 13 |
| 2011 | 3 | 7 |
| 2012 | 9 | 6 |
| 2013 | 10 | 9 |
| 2014 | 6 | 6 |
| 2015 | 8 | 6 |
| 2016 | 7 | 6 |
| 2017 | 3 | 1 |
| 2018 | 4 | 5 |
| 2019 | 4 | 1 |
| 2020 | 1 | 2 |
| 2021 | 0 | 3 |
| 2022 | 2 | 4 |
| 2023 | 4 | 7 |
| 2024 | 3 | 9 |
| 2025 | 2 | 1 |
| 2026 | 0 | 3 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Cross-linked nucleoside and nucleotide using same18 Nov 2025US 12,473,299 B2Japan AS Represented By Director General of National Institute of Health Sciences
- Solid state forms of mavacamten and process for preparation thereof25 Mar 2025US 12,258,320 B2Assia Chemical Industries Ltd.
- N-benzyl-N-arylsulfonamide derivative and preparation and use thereof28 May 2024US 11,993,576 B2Hangzhou Yirui Pharmaceutical Technology Co., Ltd
- Uracil compound containing carboxylate fragment, preparation method therefor, and herbicidal composition and use thereof16 Apr 2024US 11,958,813 B2Jiangsu Flag Chemical Industry Co., Ltd.
- Luminescent janus-type, two-coordinated metal complexes5 Mar 2024US 11,920,070 B2University of Southern California
- Compounds and compositions for intracellular delivery of nucleic acid-based therapeutics and methods thereof30 Jul 2026US 2026/0216070 A1NanoTech Pharma Inc.
- Ionizable lipidoid compositions and therapeutic uses thereof9 Apr 2026US 2026/0098014 A1Flagship Pioneering Innovations Vii, LLC
- Preparation of 2-chloro-4-fluoro-5-nitrobenzoic acid26 Mar 2026US 2026/0085051 A1Adama Agan Ltd.
- Low temperature synthesis of carbonyl-containing molecules by depolymerization of bisphenol a-based polycarbonates6 Mar 2025US 2025/0074851 A1Basque Center for Macromolecular Design and Engineering, Polymat Fundazioa
- Cyclic urea kras inhibitors31 Oct 2024US 2024/0358702 A1Incyte Corporation
Most cited
By later US patents
- Retroviral protease inhibiting compounds86US 5,914,332 AAbbott Laboratories · 1999
- Diketodiazacyclic compounds, diazacyclic compounds and combinatorial libraries thereof83US 6,441,172 B1Torrey Pines Institute for Molecular Studies · 2002
- Catechol diethers as selective PDE.sup.IV inhibitors71US 5,814,651 APfizer Inc. · 1998
- Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors60US 5,811,422 AThe DuPont Merck Pharmaceutical Company · 1998
- Allyl esters of N-alkyl-omega-(alkyleneureido) amic acids and their synthesis and use in aqueous emulsion polymer systems53US 4,111,877 AAir Products and Chemicals, Inc. · 1978